NextGen, Nipro Diagnostics create telemedicine capability monitoring diabetes patients

HORSHAM, Pa. — NextGen Healthcare Information Systems on Wednesday announced a telemedicine agreement with Nipro Diagnostics that would enable users of the company's NextGen Ambulatory EHR instant access to data points captured by patients at home who are using the Nipro TrueResult blood-glucose monitoring system. 

“Home monitoring will become even more important as healthcare providers move toward patient-centered medical home and accountable care organization models,” stated Scott Decker, president of NextGen Healthcare. “Seamlessly integrating data directly from a patient’s meter into NextGen Healthcare’s Ambulatory EHR provides physicians with the necessary tools to better manage the health of their patients with chronic disease while also affording them the ability to reduce hospitalizations and improve quality of life. This allows patients to stay at home healthier and longer before requiring interventions.”



The Nipro Diagnostic Blood Glucose interface imports blood-glucose readings from the TrueResult device into NextGen Healthcare’s Ambulatory EHR, allowing users to view and graph the information captured. The NextGen Nipro Glucose Meter Interface enables electronic downloading of glucose measurements from a Nipro Diagnostics blood-glucose meter into the EHR, automatically populating the appropriate templates and fields, where data can be viewed and analyzed by a physician.



Physicians will gain an immediate benefit from seamlessly performing diagnostic tests with direct entry of information into a patient’s chart, the company stated, eliminating the need to manually re-enter patient data while streamlining processes, reducing data entry errors and increasing efficiencies.

Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.